Veru AdComm Highlights Differing EUA Philosophies Based On Lingering COVID-19 Deaths

 
• By Sarah Karlin-Smith
  
diverging paths with arrows
FDA advisors split on whether further study of VERU-111 should come before of after an EUA • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers